Several in vitro studies have demonstrated the pivotal role of NF-κB and Nrf2 signaling pathways in mitigating LPS-induced endometritis to relieve oxidative stress and inflammatory changes when supplemented with bioactive compounds [23,24,25,26,27,28]. This evidence concerns the gene NFE2L2 and endometritis.